iHeart logo — The world's first device to calculate Internal Age™ by measu...

iHeart

The world's first device to calculate Internal Age™ by measuring a proven indicator of risk of heart disease & dementia.

Founded 1999 Canada Canada 19 employees Non Equity Assistance Total: $32.49K Health Care

General Information

Company Name iHeart
Founded Year 1999
Location Canada Canada +2
Employees 19
Industries Health Care
Funding Stage Non Equity Assistance
Social

Get notified when iHeart moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About iHeart

VitalSines is a Health Care startup founded in 2012 and headquartered in Canada. The company's flagship product, iheart Internal Age, is a groundbreaking health monitoring device and mobile app that assesses the user's Internal Age in just 30 seconds. By measuring Aortic Stiffness, a scientifically proven heart health metric, it provides valuable insights into the risk of heart disease, cognitive decline, dementia, and overall mortality. Previously, obtaining this critical health parameter required a $25,000 medical device, but iheart offers the same results for less than $200, validated against the medical 'gold standard'. The latest investment, a Non-Equity Assistance investment, was secured on 01 January 2018 from Spring Activator. The company's mission is to revolutionize health monitoring by offering a new perspective of the human body. VitalSines aims to empower consumers with actionable information, enabling them to make informed decisions about their health and ultimately lead longer, healthier lives. The team is driven by a passion for developing products that educate users about the impact of their daily actions on their internal health and lifespan. With its innovative approach and promising product offering, VitalSines presents an attractive proposition for venture capital investment in the rapidly evolving health tech sector.

Taxonomy: health tech, wearables, bio-signal analysis, heart health, mobile health, AI health coaching, health monitoring, cardiovascular health, lifestyle choices, biometric devices, optical sensors, hardware development, software health monitoring, internal age calculation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Unknown 1 Spring Activator 01 Jan 2018
Non Equity Assistance Unknown 1 01 Jan 2017
Product Crowdfunding $32.49K - 01 Dec 2014

iHeart Alternatives & Competitors

iHeart vs
PhysioWave, Inc
PhysioWave, Inc United States

PhysioWave has developed a medical scale that will provide a cardiac risk score digital biomarker in...

Series Unknown
5 employees
Biopharma, Health Care
iHeart vs
VST
VST Italy

Health through innovation

7 employees
Biotechnology, Health Care
iHeart vs

#1 Cardiovascular Health Innovator in Nigeria

Grant
15 employees
AI, Health Care

FAQ About iHeart

The world's first device to calculate Internal Age™ by measuring a proven indicator of risk of heart disease & dementia.
iHeart was founded in 1999.
iHeart is headquartered in Canada.
iHeart operates in the following industries: Health Care.
iHeart has approximately 19 employees.
iHeart has completed 3 funding rounds, raising a total of $32.49K. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to iHeart include PhysioWave, Inc, VST, Medtech Africa, Inguardia Health Inc., Lumen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
iHeart and PhysioWave, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors iHeart and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy